Fidelity Investments’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.9M | Buy |
|
|||||
|
2025
Q2 | $20.6M | Sell |
|
|||||
|
2025
Q1 | $18M | Sell |
|
|||||
|
2024
Q4 | $21.5M | Sell |
|
|||||
|
2024
Q3 | $22.2M | Buy |
|
|||||
|
2024
Q2 | $21.3M | Buy |
|
|||||
|
2024
Q1 | $23.3M | Buy |
|
|||||
|
2023
Q4 | $16.3M | Sell |
|
|||||
|
2023
Q3 | $19.4M | Sell |
|
|||||
|
2023
Q2 | $31.8M | Sell |
|
|||||
|
2023
Q1 | $38.8M | Sell |
|
|||||
|
2022
Q4 | $56.5M | Sell |
|
|||||
|
2022
Q3 | $71.1M | Sell |
|
|||||
|
2022
Q2 | $89M | Sell |
|
|||||
|
2022
Q1 | $90.8M | Buy |
|
|||||
|
2021
Q4 | $111M | Buy |
|
|||||
|
2021
Q3 | $435M | Buy |
|
|||||
|
2021
Q2 | $267M | Buy |
|
|||||
|
2021
Q1 | $664M | Buy |
|
|||||
|
2020
Q4 | $269M | Buy |
|